Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 7

Results: 13

Safety, Pharmacokinetics, and Neutralizing Activity of SYN023, a Mixture of Two Novel Antirabies Monoclonal Antibodies Intended for Use in Postrabies Exposure Prophylaxis.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 807, doi. 10.1002/cpdd.917

By:

McClain, J. Bruce;
Chuang, Ariel;
Moore, Susan M.;
Tsao, Eric

Publication type:

Article

Single‐Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment: Results From an Open‐Label, Phase 1 Trial.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 726, doi. 10.1002/cpdd.916

By:

Boinpally, Ramesh;
Jakate, Abhijeet;
Butler, Matthew;
Borbridge, Lisa;
Periclou, Antonia

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABA<sub>A</sub>‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 756, doi. 10.1002/cpdd.912

By:

Gurrell, Rachel;
Whitlock, Mark;
Wei, Hua;
Shen, Zhongzhou;
Ogden, Adam

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Healthy Japanese and Western Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 765, doi. 10.1002/cpdd.908

By:

Li, Yinhua;
Nucci, Gianluca;
Yamamoto, Yuichi;
Fediuk, Daryl J.;
Sahasrabudhe, Vaishali

Publication type:

Article

Comparison of the Pharmacokinetics of Generic Versus Branded Obeticholic Acid in a Chinese Population: Effects of Food and Sex.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 797, doi. 10.1002/cpdd.905

By:

Li, Xiaojiao;
Zhang, Hong;
Li, Cuiyun;
Zheng, Wenbo;
Wang, Meng;
Wu, Min;
Yang, Deming;
Hu, Yue;
Huo, Dandan;
Xu, Zhongnan;
Ding, Yanhua;
Liu, Li

Publication type:

Article

Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single‐Dose, Matched Case‐Control Study.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 707, doi. 10.1002/cpdd.897

By:

Masters, Joanna C.;
LaBadie, Robert R.;
Salageanu, Joanne;
Li, Jerry;
Shaik, Naveed

Publication type:

Article

Comparison of Steroidogenic Exposure Following the Administration of Repository Corticotropin Injection With a Synthetic ACTH<sub>1‐24</sub> Depot and Methylprednisolone in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 777, doi. 10.1002/cpdd.894

By:

Wang, Xiaofeng;
Pham, Loan;
Poola, Nagaraju;
Brooks, Leah R.;
Due, Bryan

Publication type:

Article

Pharmacokinetics and Safety of Chiglitazar, a Peroxisome Proliferator‐Activated Receptor Pan‐Agonist, in Patients < 65 and ≥ 65 Years With Type 2 Diabetes.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 789, doi. 10.1002/cpdd.893

By:

Li, Xiaojiao;
Yu, Jia;
Wu, Min;
Li, Qianqian;
Liu, Jingrui;
Zhang, Hong;
Zhu, Xiaoxue;
Li, Cuiyun;
Zhang, Jinwen;
Ning, Zhiqiang;
Ding, Yanhua

Publication type:

Article

Pharmacokinetics and Safety of Fosaprepitant Dimeglumine in Healthy Chinese Volunteers: Bioequivalence Study.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 748, doi. 10.1002/cpdd.892

By:

Lu, Kang;
Lin, Sisi;
Wang, Yannan;
Hao, Rui;
Fang, Lu;
Zhu, Jingjing;
Zhao, Di;
Yu, Jin;
Tong, Shengjia;
Wu, Yi;
Si, Yongkai;
Ye, Tiantian;
Yang, Qigang;
Wang, Ying

Publication type:

Article

Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 734, doi. 10.1002/cpdd.891

By:

Sun, Wan;
Lirio, Richard A.;
Schneider, Jennifer;
Aubrecht, Jiri;
Kadali, Harisha;
Baratta, Mike;
Gulati, Parul;
Suri, Ajit;
Lin, Tiffany;
Vasudevan, Raghavan;
Rosario, Maria

Publication type:

Article

Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 696, doi. 10.1002/cpdd.885

By:

Fediuk, Daryl J.;
Zhou, Susan;
Dawra, Vikas Kumar;
Sahasrabudhe, Vaishali;
Sweeney, Kevin

Publication type:

Article

Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Healthy Japanese and Caucasian Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 718, doi. 10.1002/cpdd.881

By:

Fontes, Magda S.C.;
Dingemanse, Jasper;
Sidharta, Patricia N.

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2021, v. 10, n. 7, p. 691, doi. 10.1002/cpdd.714
Publication type:: Article